A proposed neuroendocrine model of the schizophrenias.
Cowen
M A
MA
Green
M R
MR
Bertollo
D N
DN
D000328:Adult; D000368:Aged; D001921:Brain / Q000503:physiopathology; D004298:Dopamine / Q000235:genetics / Q000502:physiology; D004967:Estrogens / Q000235:genetics / Q000502:physiology; D016326:Extracellular Matrix Proteins; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology; D006801:Humans; D007375:Interleukin-1 / Q000235:genetics / Q000502:physiology; D017436:Kallmann Syndrome / Q000235:genetics / Q000503:physiopathology / Q000523:psychology; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000502:physiology; D009490:Neurosecretory Systems / Q000503:physiopathology*; D011966:Receptors, LHRH / Q000235:genetics / Q000502:physiology; D012559:Schizophrenia / Q000235:genetics / Q000503:physiopathology*; D012563:Schizophrenia, Paranoid / Q000235:genetics / Q000503:physiopathology* / Q000523:psychology; D012565:Schizophrenic Psychology
C076266:ANOS1 protein, human; D004967:Estrogens; D016326:Extracellular Matrix Proteins; D007375:Interleukin-1; D009419:Nerve Tissue Proteins; D011966:Receptors, LHRH; D004298:Dopamine